(Q51217303)

English

The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

human subject research project

0 references

1 reference

based on heuristic

inferred from title

author name string

H V Curran

1

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

M Lader

2

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

29

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

5

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

601-607

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

Physiological and psychological effects of clorazepate in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine?A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00635900

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 April 2018

http://europepmc.org/abstract/MED/3082644

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51217303&oldid=2270787774"